The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
Jan. 12, 2017
Applicants:
Nippon Chemiphar Co., Ltd., Tokyo, JP;
Kinki University, Osaka, JP;
Inventors:
Hiroto Tanaka, Tokyo, JP;
Isao Ooi, Misato, JP;
Yuzo Mogi, Misato, JP;
Masaaki Hirose, Misato, JP;
Tsuyoshi Endo, Misato, JP;
Toru Ogawa, Misato, JP;
Atsufumi Kawabata, Kashiba, JP;
Assignees:
Nippon Chemiphar Co., Ltd., Tokyo, JP;
Kinki University, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 407/12 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 235/16 (2006.01); C07D 413/14 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 491/048 (2006.01); A61K 31/4184 (2006.01); A61K 31/4025 (2006.01); A61K 31/428 (2006.01); A61K 31/5377 (2006.01); A61K 31/427 (2006.01); C07D 333/32 (2006.01); A61K 31/4245 (2006.01); A61K 31/496 (2006.01); A61K 31/381 (2006.01); A61K 31/437 (2006.01); A61K 31/423 (2006.01); A61K 31/55 (2006.01); A61K 31/343 (2006.01); A61K 31/454 (2006.01); C07D 307/81 (2006.01); A61K 31/4355 (2006.01); A61K 31/4709 (2006.01); A61P 25/04 (2006.01);
U.S. Cl.
CPC ...
C07D 235/16 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/437 (2013.01); A61K 31/4355 (2013.01); A61K 31/454 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61P 25/04 (2018.01); C07D 307/81 (2013.01); C07D 333/32 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 491/048 (2013.01);
Abstract
A compound represented by the following General Formula (I), a tautomer or a stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, is used as a voltage-dependent T-type calcium channel blocker: